文献速递胃肠外科

腹腔镜远端胃切除术后改良Billroth I与Roux-en-Y重建的欧洲倾向匹配分析

Modified Billroth I versus Roux-en-Y reconstruction after laparoscopic distal gastrectomy: Propensity-matched analysis of perioperative, pathologic, and quality-of-life outcomes in a European cohort.
PubMed 文献 · Surgery · 2025-10-30

该研究基于欧洲前瞻性队列的27对倾向匹配患者,比较钉合delta-Billroth I与Roux-en-Y重建的围术期、病理及6个月生活质量结局。Billroth I手术时间、出血量和住院时间更优,Roux-en-Y反流症状更轻但6个月体重下降更多,两组主要并发症和死亡率相当。

要点

  • Billroth I较Roux-en-Y缩短手术时间约35分钟、减少出血和住院时间。
  • Roux-en-Y反流症状更轻,但6个月体重下降更多。
  • 两组主要并发症和30天死亡率低且相当,应个体化选择重建方式。

核心结论

  • 钉合delta-Billroth I缩短手术时间且不损害早期术后结局,Roux-en-Y反流控制更优但早期体重下降更多。
  • 结果支持在微创远端胃切除术后进行个体化、以患者为中心的重建方式选择。

研究设计与样本

  • 生成27对平衡的Billroth I-Roux-en-Y配对,匹配年龄、性别、BMI、ASA体力状态、Lee指数、cT分期和新辅助治疗。
  • 主要终点为手术时间、出血量、并发症和住院时间;次要终点为病理变量和随机34+34例亚组的生活质量。

主要发现

  • Billroth I手术时间216.6±10.1分钟 vs Roux-en-Y 251.7±9.0分钟(Δ-35.1,95%CI -62.0至-8.2;P=.016)。
  • Billroth I出血量33±5 mL vs Roux-en-Y 105±11 mL(Δ-72;95%CI -106至-38;P=.003)。
  • Billroth I住院时间6.7±0.4天 vs Roux-en-Y 10.0±1.0天(Δ-3.3;95%CI -5.4至-1.2;P=.044)。
  • 主要(Clavien III-V)并发症7% vs 11%(P=.64),30天死亡率两组均为0%。
  • Roux-en-Y减少反流症状(QLQ-STO22反流-13.7;95%CI -22.3至-5.1;P=.0039),但6个月体重下降更多(-7.0 kg;95%CI -11.6至-2.4;P=.0046)。

临床怎么用

  • 在微创远端胃切除术后,可根据患者对反流控制和体重下降的偏好个体化选择Billroth I或Roux-en-Y重建。
  • Billroth I可能适合重视缩短手术时间和住院时间的患者,Roux-en-Y可能适合反流风险较高的患者。

局限性

  • 样本量较小(27对匹配),来自单中心欧洲前瞻性队列。
  • 生活质量分析基于随机34+34例亚组,随访仅6个月。
  • 仅纳入I-II期胃切除术患者,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although laparoscopic distal gastrectomy is well established, optimal reconstruction-especially in European practice-remains undefined and evidence on patient-reported outcomes is limited. We therefore conducted the first European propensity score-matched comparison of stapled delta-Billroth I versus Roux-en-Y reconstruction, examining perioperative efficiency, oncologic adequacy, and early (6-month) quality of life outcomes. METHODS: From a prospective cohort of 246 stage I-II gastrectomies (September 2022-December 2024), we generated 27 well-balanced Billroth I-Roux-en-Y pairs (matched for age, sex, body mass index, American Society of Anesthesiologists physical status, Lee index, cT stage, neoadjuvant therapy). Primary end points were operative time, blood loss, morbidity, and length of stay; secondary end points were pathologic variables and quality of life (European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30-Item and Stomach 22-Item22) in a random 34 + 34-patient subset. RESULTS: Billroth I outperformed Roux-en-Y in operative efficiency: operative time 216.6 ± 10.1 minutes vs 251.7 ± 9.0 minutes (Δ -35.1, 95% confidence interval -62.0 to -8.2; P = .016), blood loss 33 ± 5 mL vs 105 ± 11 mL (Δ -72; 95% confidence interval -106 to -38; P = .003), and hospital stay 6.7 ± 0.4 days vs 10.0 ± 1.0 days (Δ -3.3; 95% confidence interval -5.4 to -1.2; P = .044). Major (Clavien III-V) morbidity (7% vs 11%; P = .64) and 30-day mortality (0% both) were low and comparable. Quality of life global scores were similar; Roux-en-Y reduced reflux symptoms (22-Item Quality of Life Questionnaire-Stomach reflux -13.7; 95% confidence interval -22.3 to -5.1; P = .0039) but entailed greater 6-month weight loss (-7.0 kg; 95% confidence interval -11.6 to -2.4; P = .0046). CONCLUSION: Stapled delta-Billroth I shortens operative time without compromising early postoperative outcomes, whereas Roux-en-Y affords superior reflux control and is associated with greater early weight loss. These results support an individualized, patient-centered choice of reconstruction after minimally invasive distal gastrectomy.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Pomortsev B, Dalgatov K, Sinyakhin S, et al. Modified Billroth I versus Roux-en-Y reconstruction after laparoscopic distal gastrectomy: Propensity-matched analysis of perioperative, pathologic, and quality-of-life outcomes in a European cohort. Surgery. 2025. PMID: 41172884. doi:10.1016/j.surg.2025.109825

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。